104 related articles for article (PubMed ID: 29268191)
1. The cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast suppresses matrix metalloproteinase-13 expression induced by lipopolysaccharide.
Wei J; Chen S; Huang C; Guo W; Yang S; Feng B; Chu J
Int Immunopharmacol; 2018 Feb; 55():193-197. PubMed ID: 29268191
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of cysteinyl leukot-riene receptor 1 (cysLT1R) by montelukast regulates differentiation of MC3T3-E1 cells under overloaded mechanical environment.
Wei J; Chen S; Huang C; Guo W; Yang S; Feng B; Chu J
Biochem Biophys Res Commun; 2018 Jan; 495(1):995-1001. PubMed ID: 29032198
[TBL] [Abstract][Full Text] [Related]
3. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
[TBL] [Abstract][Full Text] [Related]
4. Montelukast inhibits inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes.
Dong H; Liu F; Ma F; Xu L; Pang L; Li X; Liu B; Wang L
Int Immunopharmacol; 2018 Aug; 61():215-221. PubMed ID: 29890415
[TBL] [Abstract][Full Text] [Related]
5. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
[TBL] [Abstract][Full Text] [Related]
6. The selective cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast regulates extracellular matrix remodeling.
Peng J; Zhou H; Kuang G; Xie L; Tian T; Liu R
Biochem Biophys Res Commun; 2017 Mar; 484(3):474-479. PubMed ID: 28088523
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene D4 induces cellular senescence in osteoblasts.
Wei J; Chen S; Guo W; Feng B; Yang S; Huang C; Chu J
Int Immunopharmacol; 2018 May; 58():154-159. PubMed ID: 29587204
[TBL] [Abstract][Full Text] [Related]
8. Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier.
Zhou L; Sun X; Shi Y; Liu J; Luan G; Yang Y
Inflammopharmacology; 2019 Oct; 27(5):933-940. PubMed ID: 31313075
[TBL] [Abstract][Full Text] [Related]
9. Recombinant rat CC16 protein inhibits LPS-induced MMP-9 expression via NF-κB pathway in rat tracheal epithelial cells.
Pang M; Wang H; Bai JZ; Cao D; Jiang Y; Zhang C; Liu Z; Zhang X; Hu X; Xu J; Du Y
Exp Biol Med (Maywood); 2015 Oct; 240(10):1266-78. PubMed ID: 25716019
[TBL] [Abstract][Full Text] [Related]
10. Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells.
Kuo CH; Yang SN; Kuo HF; Lee MS; Huang MY; Huang SK; Lin YC; Hsieh CC; Hung CH
Pulm Pharmacol Ther; 2016 Aug; 39():28-37. PubMed ID: 27312202
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Suppresses Matrix Metalloproteinase-2 Activation Induced by Lipopolysaccharide in Mouse Osteoblasts via Interactions with AMP-Activated Protein Kinase and Suppressor of Cytokine Signaling 1.
Yu Y; Li X; Mi J; Qu L; Yang D; Guo J; Qiu L
Molecules; 2018 Sep; 23(9):. PubMed ID: 30213073
[No Abstract] [Full Text] [Related]
12. [Effects of
Li XL; Yu YQ; Qiu LH; Yang D; Wang XM; Yu JT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Aug; 52(8):499-503. PubMed ID: 28835032
[No Abstract] [Full Text] [Related]
13. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L
Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
[TBL] [Abstract][Full Text] [Related]
14. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
15. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
Said MM; Bosland MC
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
[TBL] [Abstract][Full Text] [Related]
16. Effects of montelukast on M2-related cytokine and chemokine in M2 macrophages.
Lin YC; Huang MY; Lee MS; Hsieh CC; Kuo HF; Kuo CH; Hung CH
J Microbiol Immunol Infect; 2018 Feb; 51(1):18-26. PubMed ID: 27325144
[TBL] [Abstract][Full Text] [Related]
17. Role of cysteinyl leukotriene receptor-1 antagonists in treatment of experimentally induced mammary tumor: does montelukast modulate antitumor and immunosuppressant effects of doxorubicin?
El-Sisi Ael-D; Sokar SS; Salem TA; Abu Risha SE
Toxicol Ind Health; 2015 Nov; 31(11):1024-36. PubMed ID: 26499992
[TBL] [Abstract][Full Text] [Related]
18. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
[TBL] [Abstract][Full Text] [Related]
19. Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Induces M2 Macrophage Polarization and Inhibits Murine Aortic Aneurysm Formation.
Kawai Y; Narita Y; Yamawaki-Ogata A; Usui A; Komori K
Biomed Res Int; 2019; 2019():9104680. PubMed ID: 31263710
[TBL] [Abstract][Full Text] [Related]
20. Montelukast ameliorates streptozotocin-induced cognitive impairment and neurotoxicity in mice.
Zhang CT; Lin JR; Wu F; Ghosh A; Tang SS; Hu M; Long Y; Sun HB; Hong H
Neurotoxicology; 2016 Dec; 57():214-222. PubMed ID: 27702591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]